MeiraGTx Holdings (MGTX) Earnings Date & Reports

MeiraGTx Holdings PLC is a vertically integrated, clinical-stage genetic medicines company focused on developing targeted therapies for diseases with high unmet need, including radiation-induced xerostomia, Parkinson's disease, and AIPL1-associated retinal dystrophy... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

MGTX is expected to report earnings to fall 42.86% to -32 cents per share on August 06

MeiraGTx Holdings MGTX Stock Earnings Reports

Q2'26

Est.

$-0.33

Q1'26

Beat

by $0.05

Q4'25

Beat

by $0.75

Q3'25

Missed

by $0.12

Q2'25

Missed

by $0.01

The last earnings report on May 14 showed earnings per share of -56 cents, beating the estimate of -62 cents. With 4.27M shares outstanding, the current market capitalization sits at 1.12B.

View a ticker or compare two or three

Compare

MGTX

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days

View AI-Driven Trading for MGTX